Susan Dent, MD

Susan Dent, MD, is associate director of Breast Cancer Research, co-director of the Duke Cardio-Oncology Program, and professor of medicine at Duke University. She also currently serves as president of the International Cardio-Oncology Society, an organization dedicated to bringing cardiologists, oncologists, and allied health care providers together to improve the clinical care of patients and save lives.

Dr Dent attended McMaster University Medical School in Hamilton, Ontario, Canada, and completed her residency training in internal medicine and medical oncology at the Ottawa Hospital, University of Ottawa, Ontario. She subsequently completed a postgraduate research fellowship in clinical trials at the Canadian Cancer Trials Group in Kingston, Ontario, and was appointed as a staff medical oncologist at the Northwestern Ontario Cancer Center in Thunder Bay, Ontario.

In 2001, Dr Dent returned to Ottawa, where she specialized in the treatment of breast cancer. In 2008, she established Canada’s first multidisciplinary cardio-oncology clinic in Ottawa with her cardiology colleagues. In 2011, she founded the Canadian Cardiac Oncology Network, a not-for-profit organization devoted to optimization of cancer care for patients without compromising cardiovascular health. In 2015, Dr Dent launched the Global Cardio-Oncology Summit, an annual meeting that now attracts oncologists, cardiologists, and allied health care providers from more than 23 countries.

Dr Dent is recognized as a global leader in cardio-oncology. She has traveled extensively around the world, sharing her knowledge and expertise on the potential impact of cancer treatment on cardiovascular health. She has published extensively in this area and has coauthored several position statements and clinical practice guidelines. She continues to work and build relationships with global organizations that are interested in cardio-oncology, including the European Society of Cardio-Oncology, the American College of Cardiology, and the American Society of Clinical Oncology.